Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

DiaMedica Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference


DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that Rick Pauls, President and CEO, will participate in a fireside chat at the upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference. Management will also be available for one-on-one meetings.

A recording of the presentation will be available beginning on Monday, November 22, 2021, at 10:00a.m. Eastern Time. Interested parties may access the presentation in the "Investors" section of the company's website at https://www.diamedica.com/investors/events-presentations.

About DiaMedica Therapeutics

DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company committed to improving the lives of people suffering serious diseases. Its lead candidate DM199 is the first pharmaceutically active recombinant (synthetic) form of the KLK1 protein, an established therapeutic modality for the treatment of acute ischemic stroke (AIS) and chronic kidney disease (CKD). Based on promising early clinical results, DiaMedica has initiated and commenced enrollment in its pivotal ReMEDy Phase 2/3 trial in the treatment of AIS and is completing enrollment in its REDUX Phase 2 trial for the treatment of certain rare and significant unmet causes of CKD. For more information visit our website at www.diamedica.com.


These press releases may also interest you

at 23:18
WFES 2024: Sungrow Showcases its Advanced All-Scenario Renewable Energy Solutions in Abu Dhabi
Sungrow, the global leading PV inverter and energy storage system provider, exhibited its cutting-edge and comprehensive renewable energy solutions at the World Future Energy Summit (WFES) 2024. Notably, Sungrow has achieved a remarkable milestone by...

at 23:16
Advantech Collaborates with Phison to Develop GenAI Computing Platform for Edge and Industrial Applications
The emergence of Generative AI (GenAI) has led to the widespread use of AI assistants across various sectors including business environments, education, healthcare, legal and accounting fields, banking, and even migration into embedded and industrial...

at 23:03
TaiGen Successfully Completes TG-1000 Phase III Study
TaiGen Biotechnology Company, Limited ("TaiGen") announces today that the business partner, Joincare Pharmaceutical, has completed the unblinding of influenza antiviral TG-1000 phase III study. Preliminary data shows that the median time to...

at 22:52
CO280 and Aker Carbon Capture collaborate with Microsoft to scale-up permanent, affordable carbon removal in US and Canada
CO280 and Aker Carbon Capture have signed a Memorandum of Understanding (MoU) agreement with Microsoft to explore...

at 22:34
Flash News: OKX Partners with OverProtocol to Launch Airdrop Event on Cryptopedia
OKX, a leading Web3 technology company, has issued updates for April 17, 2024. OKX Partners with OverProtocol to Launch Airdrop Event...

at 21:57
Serve Robotics Inc. Announces Pricing of $40 Million Public Offering and Uplisting to the Nasdaq Capital Market Under New Ticker "SERV"
Serve Robotics Inc. (the "Company" or "Serve"), a leading autonomous sidewalk delivery company, today announced the pricing of its underwritten public offering of 10,000,000 shares of common stock at a price to the public of $4.00 per share, for...

More news about Science and technology...


News published on and distributed by: